Search research articles
Contact Us
Filters
Showing results (21-30 of 407) with videos related to
Page
of 41
Sort By:
Elife
|
October 8, 2015
What makes an eLife paper in epidemiology and global health?
Mark Jit, Eduardo Franco, Prabhat Jha
Lancet (London, England)
|
June 4, 2021
Divergent vaccination policies could fuel mistrust and hesitancy
Rebecca Forman, Mark Jit, Elias Mossialos
Vaccine
|
August 29, 2015
Targeted vaccination in healthy school children - Can primary school vaccination alone control influenza?
Dominic Thorrington, Mark Jit, Ken Eames
Vaccine
|
July 9, 2013
Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: a systematic review
Michaela Fesenfeld, Raymond Hutubessy, Mark Jit
Pharmacoeconomics
|
July 14, 2012
Economic evaluations of childhood influenza vaccination: a critical review
Anthony T Newall, Mark Jit, Philippe Beutels
Plos Computational Biology
|
September 13, 2017
Projecting social contact matrices in 152 countries using contact surveys and demographic data
Kiesha Prem, Alex R Cook, Mark Jit
Expert Review of Pharmacoeconomics & Outcomes Research
|
April 17, 2014
Key issues and challenges in estimating the impact and cost-effectiveness of quadrivalent influenza vaccination
Emma Quinn, Mark Jit, Anthony T Newall
BMC Medicine
|
September 6, 2018
Cost-benefit analysis of vaccination: a comparative analysis of eight approaches for valuing changes to mortality and morbidity risks
Minah Park, Mark Jit, Joseph T Wu
Human Vaccines & Immunotherapeutics
|
January 30, 2013
Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies
Mark Jit, Anthony T Newall, Philippe Beutels
BMJ (Clinical Research Ed.)
|
July 22, 2008
Economic evaluation of human papillomavirus vaccination in the United Kingdom
Mark Jit, Yoon Hong Choi, W John Edmunds
Page
of 41
Search research articles
Search
Showing results (21-30 of 407) with videos related to
Sort By:
Page
of 41
Elife
|
October 8, 2015
What makes an eLife paper in epidemiology and global health?
Mark Jit, Eduardo Franco, Prabhat Jha
Lancet (London, England)
|
June 4, 2021
Divergent vaccination policies could fuel mistrust and hesitancy
Rebecca Forman, Mark Jit, Elias Mossialos
Vaccine
|
August 29, 2015
Targeted vaccination in healthy school children - Can primary school vaccination alone control influenza?
Dominic Thorrington, Mark Jit, Ken Eames
Vaccine
|
July 9, 2013
Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: a systematic review
Michaela Fesenfeld, Raymond Hutubessy, Mark Jit
Pharmacoeconomics
|
July 14, 2012
Economic evaluations of childhood influenza vaccination: a critical review
Anthony T Newall, Mark Jit, Philippe Beutels
Plos Computational Biology
|
September 13, 2017
Projecting social contact matrices in 152 countries using contact surveys and demographic data
Kiesha Prem, Alex R Cook, Mark Jit
Expert Review of Pharmacoeconomics & Outcomes Research
|
April 17, 2014
Key issues and challenges in estimating the impact and cost-effectiveness of quadrivalent influenza vaccination
Emma Quinn, Mark Jit, Anthony T Newall
BMC Medicine
|
September 6, 2018
Cost-benefit analysis of vaccination: a comparative analysis of eight approaches for valuing changes to mortality and morbidity risks
Minah Park, Mark Jit, Joseph T Wu
Human Vaccines & Immunotherapeutics
|
January 30, 2013
Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies
Mark Jit, Anthony T Newall, Philippe Beutels
BMJ (Clinical Research Ed.)
|
July 22, 2008
Economic evaluation of human papillomavirus vaccination in the United Kingdom
Mark Jit, Yoon Hong Choi, W John Edmunds
Page
of 41